Corsicana & Co.

Position in RNA — Atrium Therapeutics, Inc.

CIK 1869923 CORSICANA, TX

Position in RNA

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$132,079

New position

Shares Held

9,820

first reported quarter

Ownership

0.057%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#6

of 20 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 46% Shared 54% None 0%

Healthcare · as of Jun 30, 2026

Corsicana & Co. holds $137,553 across 3 Biotechnology names. RNA ranks #1 (96.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RNA	Atrium Therapeutics, Inc. This page	9,820	$132,079
2	VRTX	Vertex Pharmaceuticals Inc / Ma	6	$2,980
3	REGN	Regeneron Pharmaceuticals, Inc.	4	$2,494

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$132,079	9,820	—	Shares	Sole	2026-07-24
No filing history on record for this holder in this stock.